Nerelimomab
Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.[1]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | TNF alpha |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG |
|
|
References
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.